CDT Equity Switches Auditors to Strengthen Oversight Amid Health‑Care Growth
CDT Equity Inc. shifts to Carr, Riggs & Ingram to boost audit rigor, amid stock volatility and ongoing health‑care innovation efforts.
2 minutes to read
CDT EQUITY INC
CDT Equity Expands Beyond Healthcare, Investing $115M in AI & Launching Election Cybersecurity Initiative
CDT Equity’s $115 M stake in AI firm Sarborg and new election‑cybersecurity initiative show San Diego‑based life‑science company expanding beyond healthcare into tech‑driven growth.
3 minutes to read
CDT Equity Inc. Announces Reverse Stock Split Amid Extreme Volatility and Financial Uncertainty
CDT Equity Inc. announces a reverse stock split amid extreme volatility—learn how this move could reshape its market cap and investor outlook.
2 minutes to read
CDT Equity Launches Reverse Stock Split & Solid‑Form Licensing Deal with NJS Foresight
CDT Equity Inc. announces a reverse stock split and a new solid‑form licensing partnership with NJS Foresight to boost share price and unlock drug‑delivery IP.
2 minutes to read
CDT Equity Inc.: Navigating Volatility and High Risk in the Biotech Sector
CDT Equity Inc. is a micro-cap biotech company with a focus on repurposing pharmaceutical assets, but its negative earnings and high volatility pose significant risks, making it a speculative investment opportunity.
3 minutes to read
CDT Equity Inc. Leverages Drug Repurposing to Innovate in Health-Care Sector
CDT Equity Inc. is a small-cap health-care company that has carved a niche for itself by developing clinical assets that larger pharmaceutical entities have deprioritized, offering a compelling investment opportunity for value-oriented investors.
3 minutes to read